In NK cell-specific SPON2-knockout mouse models, the researchers observed decreased IFN-γ secretion and impaired NK cell infiltration, leading to accelerated tumor progression.

In NK cell-specific SPON2 knockout mouse models, the researchers observed decreased IFN-γ secretion and impaired NK cell infiltration, leading to accelerated tumor progression.

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

A team of researchers from the Hospital del Mar Research Institute, the Universitat Autònoma de Barcelona and the Pompeu Fabra University has developed a new tool that allows modifying these NK cells ...

Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...

Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic "marks" in a transition state between ...